BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36695326)

  • 1. Long-Term Visit-to-Visit Glycemic Variability as a Predictor of Major Adverse Limb and Cardiovascular Events in Patients With Diabetes.
    Hsu JC; Yang YY; Chuang SL; Huang KC; Lee JK; Lin LY
    J Am Heart Assoc; 2023 Feb; 12(3):e025438. PubMed ID: 36695326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher long-term visit-to-visit glycemic variability predicts new-onset atrial fibrillation in patients with diabetes mellitus.
    Hsu JC; Yang YY; Chuang SL; Yu CC; Lin LY
    Cardiovasc Diabetol; 2021 Jul; 20(1):148. PubMed ID: 34301257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High hemoglobin A
    Arya S; Binney ZO; Khakharia A; Long CA; Brewster LP; Wilson PW; Jordan WD; Duwayri Y
    J Vasc Surg; 2018 Jan; 67(1):217-228.e1. PubMed ID: 28844470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visit to Visit Hemoglobin A1c Variation and Long-term Risk of Major Adverse Limb Events in Patients With Type 2 Diabetes.
    Hsiao FC; Chan YH; Tung YC; Lin CP; Lee TH; Wang YC; Chu PH
    J Clin Endocrinol Metab; 2023 Sep; 108(10):2500-2509. PubMed ID: 37022983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study.
    Ding N; Kwak L; Ballew SH; Jaar B; Hoogeveen RC; Ballantyne CM; Sharrett AR; Folsom AR; Heiss G; Salameh M; Coresh J; Hirsch AT; Selvin E; Matsushita K
    Atherosclerosis; 2018 Jul; 274():86-93. PubMed ID: 29753232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visit-to-Visit HbA
    Li S; Nemeth I; Donnelly L; Hapca S; Zhou K; Pearson ER
    Diabetes Care; 2020 Feb; 43(2):426-432. PubMed ID: 31727686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Glycemic Variability and Vascular Complications in Type 2 Diabetes: Post Hoc Analysis of the FIELD Study.
    Scott ES; Januszewski AS; O'Connell R; Fulcher G; Scott R; Kesaniemi A; Wu L; Colagiuri S; Keech A; Jenkins AJ
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32766757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting plasma glucose variability and HbA1c are associated with peripheral artery disease risk in type 2 diabetes.
    Yang CP; Lin CC; Li CI; Liu CS; Lin CH; Hwang KL; Yang SY; Li TC
    Cardiovasc Diabetol; 2020 Jan; 19(1):4. PubMed ID: 31910828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Risk of Cardiovascular Disease Among Type 2 Diabetes Patients According to Average and Visit-to-Visit Variations of HbA1c Levels During the First 3 Years of Diabetes Diagnosis.
    Kim H; Jung DY; Lee SH; Cho JH; Yim HW; Kim HS
    J Korean Med Sci; 2023 Jan; 38(4):e24. PubMed ID: 36718561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of acute glycemic variability on short-term outcomes in patients with ST-segment elevation myocardial infarction: a multicenter population-based study.
    Wang J; Wang LL; Yang YM; Tan HQ; Zhu J
    Cardiovasc Diabetol; 2024 May; 23(1):155. PubMed ID: 38715023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycemic variability evaluated by HbA1c rather than fasting plasma glucose is associated with adverse cardiovascular events.
    Sheng L; Yang G; Chai X; Zhou Y; Sun X; Xing Z
    Front Endocrinol (Lausanne); 2024; 15():1323571. PubMed ID: 38419951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limb and cardiovascular event risk in type 1 and 2 diabetic patients with peripheral artery disease.
    Sykora D; Firth C; Girardo M; Tseng A; Wennberg P; Liedl D; Shamoun F
    Vasa; 2023 Sep; 52(5):310-316. PubMed ID: 37519117
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma concentrations of lipoproteins and risk of lower-limb peripheral artery disease in people with type 2 diabetes: the SURDIAGENE study.
    Bertrand C; Saulnier PJ; Potier L; Croyal M; Blanchard V; Gand E; Ragot S; Schneider F; Bocock O; Baillet-Blanco L; Velho G; Marre M; Roussel R; Rigalleau V; Hadjadj S; Mohammedi K;
    Diabetologia; 2021 Mar; 64(3):668-680. PubMed ID: 33409569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Moram CBM; Salles GF
    Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of fasting plasma glucose variability on the risk of incident peripheral artery disease in a population without diabetes: a nationwide population-based cohort study.
    Chung HS; Hwang SY; Kim JA; Roh E; Yoo HJ; Baik SH; Kim NH; Seo JA; Kim SG; Kim NH; Choi KM
    Cardiovasc Diabetol; 2022 Jan; 21(1):15. PubMed ID: 35101050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Waist circumference is associated with major adverse cardiovascular events in male but not female patients with type-2 diabetes mellitus.
    Xing Z; Peng Z; Wang X; Zhu Z; Pei J; Hu X; Chai X
    Cardiovasc Diabetol; 2020 Mar; 19(1):39. PubMed ID: 32213183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study.
    Mohammedi K; Woodward M; Hirakawa Y; Zoungas S; Colagiuri S; Hamet P; Harrap S; Poulter N; Matthews DR; Marre M; Chalmers J;
    Cardiovasc Diabetol; 2016 Sep; 15(1):129. PubMed ID: 27590190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk associations of long-term HbA1c variability and obesity on cancer events and cancer-specific death in 15,286 patients with diabetes - A prospective cohort study.
    Mao D; Lau ESH; Wu H; Yang A; Shi M; Fan B; Tam CHT; Chow E; Kong APS; Ma RCW; Luk A; Chan JCN
    Lancet Reg Health West Pac; 2022 Jan; 18():100315. PubMed ID: 35024653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Long-Term HbA1c Variability and Functional Limitation in Individuals Aged Over 50 Years: A Retrospective Cohort Study.
    Shao D; Wang SS; Sun JW; Wang HP; Sun Q
    Front Endocrinol (Lausanne); 2022; 13():847348. PubMed ID: 35574024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor glycemic control is associated with significant increase in major limb amputation and adverse events in the 30-day postoperative period after infrainguinal bypass.
    McGinigle KL; Kindell DG; Strassle PD; Crowner JR; Pascarella L; Farber MA; Marston WA; Arya S; Kalbaugh CA
    J Vasc Surg; 2020 Sep; 72(3):987-994. PubMed ID: 32139308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.